Gleolan
Showing 1 - 6 of 6
Ovarian Cancer Trial (Gleolan)
Not yet recruiting
- Ovarian Cancer
- Gleolan
- (no location specified)
Mar 27, 2023
Meningioma Trial in Austria, Germany, United States (Gleolan (Aminolevulinic Acid Hydrochloride/ALA/ALA-HCI))
Active, not recruiting
- Meningioma
- Gleolan (Aminolevulinic Acid Hydrochloride/ALA/ALA-HCI)
-
Phoenix, Arizona
- +16 more
Dec 27, 2022
High Grade Glioma Trial in Lake Success (5 Aminolevulinic Acid, CV01-delivered ultrasound)
Recruiting
- High Grade Glioma
- 5 Aminolevulinic Acid
- CV01-delivered ultrasound
-
Saint Louis, Missouri
- +2 more
Dec 21, 2022
5-Aminolevulinic Acid Gliolan®: Usage Increase Proposal for
Not yet recruiting
- High Grade Glioma
- +10 more
- 5-Aminolevulinic Acid (5-ALA) Gliolan®
- Fluorescence-Guided Surgery using 5-aminolevulinic acid (5-ALA)
-
Guayaquil, Guayas, EcuadorSociedad de Lucha Contra el Cáncer
Apr 28, 2023
Tumor, Skull Base Tumor Trial in New York (5-Aminolevulinic acid Hydrochloride)
Recruiting
- Neoplasm
- Skull Base Neoplasm
- 5-Aminolevulinic acid Hydrochloride
-
New York, New York
- +2 more
Oct 28, 2021
Recurrent Glioblastoma, Glioblastoma Multiforme, GBM Trial in Charlottesville (5-ALA and Low-Intensity Focused Ultrasound (SDT))
Not yet recruiting
- Recurrent Glioblastoma
- +2 more
- 5-ALA and Low-Intensity Focused Ultrasound (SDT)
-
Charlottesville, VirginiaUniversity of Virginia
Sep 10, 2023